Keyword: Teva Pharmaceutical Industries
News
02.05.2013
- Teva Pharmaceutical Industries is banking on approval in early 2014 for a new thrice-weekly version of its multiple sclerosis treatment Copaxone to bolster sales ahead of a likely...
News
02.04.2013
- Neurological and dermatology drugs maker Merz Pharma offered to buy cosmetic products maker Obagi Medical Products for $383.5 million, topping a bid by Canada's Valeant...
News
05.03.2013
- U.S. regulators granted Pfizer a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on...
News
06.12.2012
- Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin has promised investors it will be a very different company going forward. Next week he has to prove it. Levin's...
News
01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
News
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
News
19.07.2012
- Pfizer beat back a challenge from generic drugmakers to a patent that protects its pain medicine Lyrica, its second-best selling drug when a federal judge ruled in its favor on...
News
24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
